Trine Strandgaard

Arhus, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Impact of Photodynamic Diagnosis on Immune Cell Infiltration in BCG-treated Non-muscle-invasive Bladder Cancer.

Impact of Photodynamic Diagnosis on Immune Cell Infiltration in BCG-treated Non-muscle-invasive Bladder Cancer.

Journal: European urology open science

Published: July 16, 2026

ctDNA-guided immunotherapy following radical cystectomy for muscle-invasive bladder cancer: results from the TOMBOLA trial.

ctDNA-guided immunotherapy following radical cystectomy for muscle-invasive bladder cancer: results from the TOMBOLA trial.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: November 03, 2025

Circulating tumour DNA and circulating tumour cells in bladder cancer - from discovery to clinical implementation.

Circulating tumour DNA and circulating tumour cells in bladder cancer - from discovery to clinical implementation.

Journal: Nature reviews. Urology

Published: March 14, 2025

Expression of PD-1 and PD-L1 in BCG-treated NMIBC.

Expression of PD-1 and PD-L1 in BCG-treated NMIBC.

Journal: Bladder cancer (Amsterdam, Netherlands)

Published: March 13, 2025

HLA-E and NKG2A Mediate Resistance to BCG Immunotherapy in Non-Muscle-Invasive Bladder Cancer.

HLA-E and NKG2A Mediate Resistance to BCG Immunotherapy in Non-Muscle-Invasive Bladder Cancer.

Journal: bioRxiv : the preprint server for biology

Published: September 16, 2024

Low T cell diversity associates with poor outcome in bladder cancer: A comprehensive longitudinal analysis of the T cell receptor repertoire.

Low T cell diversity associates with poor outcome in bladder cancer: A comprehensive longitudinal analysis of the T cell receptor repertoire.

Journal: Cell reports. Medicine

Published: August 30, 2024

Comprehensive genomic characterization of early-stage bladder cancer.

Comprehensive genomic characterization of early-stage bladder cancer.

Journal: Nature genetics

Published: October 31, 2023

Multiomics profiling of urothelial carcinoma in situ reveals CIS-specific gene signature and immune characteristics.

Multiomics profiling of urothelial carcinoma in situ reveals CIS-specific gene signature and immune characteristics.

Journal: iScience

Published: June 26, 2023

Field Cancerization Is Associated with Tumor Development, T-cell Exhaustion, and Clinical Outcomes in Bladder Cancer.

Field Cancerization Is Associated with Tumor Development, T-cell Exhaustion, and Clinical Outcomes in Bladder Cancer.

Journal: European urology

Published: March 28, 2023

Single-nucleus and Spatially Resolved Intratumor Subtype Heterogeneity in Bladder Cancer.

Single-nucleus and Spatially Resolved Intratumor Subtype Heterogeneity in Bladder Cancer.

Journal: European urology open science

Published: March 13, 2023

Cell-Free Urine and Plasma DNA Mutational Analysis Predicts Neoadjuvant Chemotherapy Response and Outcome in Patients with Muscle-Invasive Bladder Cancer.

Cell-Free Urine and Plasma DNA Mutational Analysis Predicts Neoadjuvant Chemotherapy Response and Outcome in Patients with Muscle-Invasive Bladder Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: October 25, 2022

Biology of BCG response in non-muscle invasive bladder cancer - 2021 IBCN Updates Part III.

Biology of BCG response in non-muscle invasive bladder cancer - 2021 IBCN Updates Part III.

Journal: Urologic oncology

Published: May 09, 2022

Showing 1-12 of 16

Last Updated: 09/26/2026